{"schema_version":"secwatch.filing_event.v1","accession":"0001562762-23-000305","form_type":"8-K","ticker":"GMED","cik":"0001237831","company_name":"GLOBUS MEDICAL INC","filed_at":"2023-08-03T23:59:59+00:00","discovered_at":"2026-05-14T18:03:33.371295+00:00","generated_at":"2026-06-12T07:21:40.080452+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Globus Medical Q2 net sales $292M (+10.6% YoY); raises FY 2023 guidance to $1.125B","bullets":["Net sales $291.6M, up 10.6% YoY; GAAP net income $57.7M (+5.7%).","GAAP diluted EPS $0.57; non-GAAP diluted EPS $0.63 (+12.3%).","Non-GAAP adjusted EBITDA $96.1M (33.0% of sales).","Raised FY 2023 net sales guidance to $1.125B (from $1.100B); reaffirmed non-GAAP EPS $2.30.","Launched REFLECT Scoliosis Correction System and MARVEL Growing Rod System."],"urls":{"canonical":"https://secwatch.observer/filing/0001562762-23-000305","json":"https://secwatch.observer/filing/0001562762-23-000305.json","markdown":"https://secwatch.observer/filing/0001562762-23-000305.md","text":"https://secwatch.observer/filing/0001562762-23-000305.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1237831/000156276223000305/0001562762-23-000305-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1237831/000156276223000305/gmed-20230803x8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-12T07:21:40.080452+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"00304af716efd65f7c281f216abf36de49bbcc07","claim":"GLOBUS MEDICAL INC updated its three-month period ended June 30, 2023 guidance (raised).","evidence_excerpt":"On August 3, 2023, we issued a press release reporting, among other things, our sales and operating results for the three-month period ended June 30, 2023.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1237831/000156276223000305/0001562762-23-000305-index.htm","confidence":0.75,"family_label":"Earnings Releases","details":[{"label":"Period","value":"three-month period ended June 30, 2023"},{"label":"Guidance","value":"raised"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}